Muscarinic receptor binding sites of the M4 subtype in porcine lung parenchyma

被引:10
作者
Chelala, JL
Kilani, A
Miller, MJ
Martin, RJ
Ernsberger, P
机构
[1] Case Western Reserve Univ, Sch Med, Dept Paediat, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA
[4] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA
来源
PHARMACOLOGY & TOXICOLOGY | 1998年 / 83卷 / 05期
关键词
D O I
10.1111/j.1600-0773.1998.tb01469.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Muscarinic acetylcholine receptors regulate distal airway resistance and secretion. The subtype expressed in the lung in different species remains uncertain. It has recently become possible to identify the M-4 subtype by careful comparison of antagonist affinities. We characterized the binding of [H-3]quinuclidinyl benzilate ([H-3]QNB) to muscarinic receptors in cell membranes from lung parenchyma of 2-8 week old pigs in comparison to cloned human M-3 and M-4 receptors expressed in COS cells, to M-2 in rat atria and to M-4 in bovine adrenal medulla. In porcine lung, [H-3]QNB bound with high affinity (K-d = 95+/-9pM) to a single homogeneous population of muscarinic receptor sites (B-max = 340+/-10 fmol/mg protein). Competition studies showed that the affinity (expressed as pK(i)) of 3 selective blockers was in close agreement between pig lung and cloned human m(4) (r=0.996). A series of 10 blockers showed affinities closely matching reported values for M-4 receptors of the adrenal medulla (r=0.965). Conversely, affinity values in porcine lung differed significantly (P< 0.05, t-test) from those determined in parallel with either human cloned M-3 or with rat atria expressing the M-2 subtype. We conclude that pig lung muscarinic receptor binding sites most closely resemble the M-4 subtype, in contrast to the M-3 subtype typical of large airways in this species.
引用
收藏
页码:200 / 207
页数:8
相关论文
共 44 条
[1]   MUSCARINIC RECEPTOR SUBTYPES IN AIRWAYS [J].
BARNES, PJ .
LIFE SCIENCES, 1993, 52 (5-6) :521-527
[2]  
DONG GZ, 1995, J PHARMACOL EXP THER, V274, P378
[3]  
DOODS HN, 1987, J PHARMACOL EXP THER, V242, P257
[4]  
DORJE F, 1991, J PHARMACOL EXP THER, V256, P727
[5]   Maturational changes in responses of tissue and airway resistance to histamine [J].
Dreshaj, IA ;
Haxhiu, MA ;
Potter, CF ;
Agani, FH ;
Martin, RJ .
JOURNAL OF APPLIED PHYSIOLOGY, 1996, 81 (04) :1785-1791
[6]   ADDITIONAL COMPLEXITIES IN THE BINDING OF MUSCARINIC RECEPTOR ANTAGONISTS [J].
ELFAKAHANY, EE .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1985, 6 (11) :430-431
[7]   EXPRESSION OF MUSCARINIC RECEPTOR SUBTYPES AND M(2)-MUSCARINIC INHIBITION OF ADENYLYL-CYCLASE IN LUNG [J].
EMALA, CW ;
ARYANA, A ;
LEVINE, MA ;
YASUDA, RP ;
SATKUS, SA ;
WOLFE, BB ;
HIRSHMAN, CA .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1995, 268 (01) :L101-L107
[8]   REFEEDING HYPERTENSION IN OBESE SPONTANEOUSLY HYPERTENSIVE RATS [J].
ERNSBERGER, P ;
KOLETSKY, RJ ;
BASKIN, JS ;
FOLEY, M .
HYPERTENSION, 1994, 24 (06) :699-705
[9]  
ERNSBERGER P, 1991, CLIN RES, V39, pA706
[10]  
EVINGER MJ, 1994, J NEUROSCI, V14, P2106